Physician

Christopher Todd Payne, MD

According to 2025 Medicare claims, Christopher Payne, MD (NPI: 1558363507) practices urology in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is COLLOM & CARNEY CLINIC ASSOCIATION (NPI: 1700868528; TIN: 751151440) and primary practice location at 75503-4610. Payne is affiliated with the Prime Care Managers, LLC (ACO ID: A3280), participating under the MSSP model.

Payne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,136 traditional Medicare patients, billed 27,543 HCPCS/CPT codes, and received $319,311 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,465 prescription claims across 935 beneficiaries totaling $185,118 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 155 claims. Open Payments data shows 28 records totaling $601. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $627 to $1,998.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$160K$319K2015 Medicare payment: $228,983 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $282,924 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $242,321 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $213,875 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $252,697 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $250,547 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $266,390 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $296,340 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $308,520 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $319,311 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,09914,956$228,983
20161,21816,779$282,924
20171,20619,077$242,321
20181,06617,000$213,875
20191,08621,084$252,697
20201,02421,085$250,547
20211,06315,310$266,390
20221,10718,141$296,340
20231,12124,900$308,520
20241,13627,543$319,311

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$93K$185K2015 Drug cost: $146,393 (USD; Tot_Drug_Cst)2016 Drug cost: $161,327 (USD; Tot_Drug_Cst)2017 Drug cost: $150,467 (USD; Tot_Drug_Cst)2018 Drug cost: $120,859 (USD; Tot_Drug_Cst)2019 Drug cost: $110,963 (USD; Tot_Drug_Cst)2020 Drug cost: $114,069 (USD; Tot_Drug_Cst)2021 Drug cost: $140,276 (USD; Tot_Drug_Cst)2022 Drug cost: $127,201 (USD; Tot_Drug_Cst)2023 Drug cost: $155,206 (USD; Tot_Drug_Cst)2024 Drug cost: $185,118 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154662,471$146,393
20165142,605$161,327
20175362,543$150,467
20184972,498$120,859
20195212,395$110,963
20205612,744$114,069
20215962,791$140,276
20226503,125$127,201
20237783,849$155,206
20249354,465$185,118

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$31K$62K2015 Medicare payment: $27,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $36,925 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $28,241 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $33,546 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $61,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $54,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $32,693 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $29,847 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $30,772 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $25,695 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R98$27,988
2016N/R175$36,925
2017N/R137$28,241
2018N/R179$33,546
2019N/R247$61,857
2020N/R247$54,635
2021N/R203$32,693
2022N/R148$29,847
2023N/R160$30,772
2024N/R155$25,695

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8831,190$62
84153Psa (prostate specific antigen) measurement, total503620$18
36415Insertion of needle into vein for collection of blood sample549684$9
51798Ultrasound measurement of bladder capacity after voiding259390$8
81001Manual urinalysis test with examination using microscope, automated9651,499$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron1164,800$71,481
GemtesaVibegron341,260$19,900
Tamsulosin HclTamsulosin Hcl1,39784,105$15,931
FinasterideFinasteride1,11867,939$14,107
TrimethoprimTrimethoprim2338,802$10,886

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R45$11,920
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R15$11,827
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R15$559
A4358Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, eachNN/R18$491
A4332Lubricant, individual sterile packet, eachNN/R25$363

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$601Sumitomo Pharma America, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Todd Payne, MD?

Tedicare shows public-source Medicare data for Christopher Todd Payne, MD (NPI 1558363507), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Todd Payne, MD have ACO affiliation data?

Christopher Todd Payne, MD is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280).

What billing organization is linked to Christopher Todd Payne, MD?

Christopher Todd Payne, MD is linked to COLLOM & CARNEY CLINIC ASSOCIATION (billing NPI 1700868528) in the available physician profile data.

Does Christopher Todd Payne, MD have Open Payments data?

Christopher Todd Payne, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.